Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fully automated glycemic control with Lyumjev in a bihormonal closed-loop system in type 1 diabetes
2022-001373-31Phase 4Completed
- Sponsor
- Inreda Diabetic
- Start
- May 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of insulin lispro in diabetes mellitus type 1 (T1D) (2 arms), sponsored by Inreda Diabetic. Primary endpoint: Primary efficacy endpoint. Started May 2022; status: completed.
02
Drugs
insulin lispro
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2022-001373-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-001373-31.